Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-site, Open-label Non-inferiority Trial to Assess Immunogenicity of Two Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults (9-26 Years) Living With HIV vs Three Doses of Nonavalent HPV Vaccine Among HIV Uninfected Young Women (15-26 Years) in Eswatini

NCT04982614 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04982614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04982614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-site, Open-label Non-inferiority Trial to Assess Immunogenicity of Two Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults (9-26 Years) Living With HIV vs Three Doses of Nonavalent HPV Vaccine Among HIV Uninfected Young Women (15-26 Years) in Eswatini
Lead sponsor
Columbia University
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2022
Completion date
December 9, 2024
Enrollment
1,403 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hpv infection, hpv vaccine